Home - Cancerworld

Tackling resistance to anti-EGFR therapies, from challenges to re-challenge

New technologies and innovative approaches can help preventing and overcome innate or acquired resistance to EGFR inhibitors, improving their therapeutic effects Since their first approval and use, more than 15 years ago, inhibitors of the [more]
ABC5 reaches an agreement on advanced breast cancer

Cancerworld witnessed the final consensus meeting that produced the new guidelines on advanced breast cancer. The consensus panel gathered in Lisbon during ABC5 to discuss, and sometimes to disagree. At the end, the experts voted more than 50 statements, some of them totally new for the topic [more]
Fear and lack of training may condemn cancer patients to live in pain

The US restrictions on the prescription of opioids had barely any effect in reducing opioid-related deaths, but are menacing the proper pain management care in cancer patients — and other chronic pain patients, Vera Novais [more]
Expectations in ovarian cancer: foreseeing the next year

A special multidisciplinary session on ovarian cancer took place during the European Congress on Gynaecological Oncology, in Athens, with the aim of predicting what will happen in the field of ovarian cancer in the near [more]
Biosimilars ‒ Policy failings that deny savings to countries that need it most

Competitor drugs entering the market are opening opportunities to make important savings on an increasing number of biological anticancer agents. But, as Rachel Brazil reports, many countries, including those with the most stretched health budgets, [more]
How to become the best cancer doctor you can be

If your ambition is to excel at the oncology career you have chosen, you have to find your own pathway to success. Anna Wagstaff talked to three early-career oncologists who are trying to do just [more]
Is precision medicine ignoring people dying of cancer?

While we’re pouring resources into learning what keeps cancer cells alive, with the aim of blocking their supply lines, there is next to no interest in the molecular pathways that end up choking the life [more]
Maria Nazinkina Del Grande: bridging two worlds

A daughter and granddaughter of Russian heads of radiology, now living and working in southern Switzerland, medical oncologist Maria Nazinkina Del Grande is keen to play a part in bringing her two worlds closer together. [more]
The future is digital – but is it safe?

Joined-up patient-centred care requires sharing of data between patients, oncologists, hospitals, labs, GPs, nurses and even social care. But as apps designed to gather and share this data proliferate, so does the risk that the [more]
NETs – Why this master of disguise needs careful handling

Rare, hard to recognise, with primaries occurring at many different sites and associated with a wide variety of symptoms, tumours of the neuroendocrine system (NETs) are often detected too late to cure, and can be [more]

Real-world evidence in oncology has benefits (and risks)

News 13 January 2020 0

Despite some weaknesses, real-world data can have a pivotal role in oncology, helping researchers and physicians to better understand the efficacy of anti-cancer treatments and how to manage [more]
Artificial intelligence is prone to overdiagnosis

News 7 January 2020 0

The use of artificial intelligence might increase the speed and the consistency of cancer diagnosis, but could also exacerbate the problem of overdiagnosis, according to a perspective article recently [more]

Cancerworld’s Albini in the list of top scientists

in the media 20 September 2019 0

Adriana Albini, the new editor in Chief of Cancerworld, is mentioned very high in the list of top 100,000 world scientists compiled by a group of experts of research methodology. [more]

© Copyright ESO 2018 with all rights reserved - Credits -

Privacy Policy Cookie Policy

UA-77507851-1